Cytolin mouse anti-human monoclonal antibody selectively targeting a subset of CD8 cells: Phase I/II trial

CytoDyn Inc., Los Angeles, Calif.
Product:

Read the full 64 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE